Depression and Anxiety Trial, By Invitation NCT06760689 Sponsor: Çankırı Karatekin University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, By Invitation

NCT06760689
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are over 18 years old.
  • People who have been diagnosed with Stage 1, 2, or 3 of their condition.
  • People who are aware of their own diagnosis.
  • People who are able to read and write in Turkish.
  • People who have no history of seizures.
  • People who do not have cancer that has spread to the brain.
  • People who have not been diagnosed with a psychiatric disorder or dementia.
  • People whose treatment is given in 21-day cycles.
  • People who are physically able to wear and use virtual reality glasses.
  • People who do not have any visual or hearing impairment.
  • People who are participating voluntarily.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have Stage 4 of their condition.
  • People who experience vertigo.
  • People who experience severe nausea and vomiting during pregnancy.
  • People who experience nausea and vomiting during travel (such as motion sickness).
  • People who have a visual or hearing impairment.
  • People who are unaware of their cancer diagnosis, or who have been diagnosed with cancer but have not yet started treatment or have already completed their treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Çankırı Karatekin University
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
31 March 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Effect of Virtual Reality Glasses on Treatment Adherence and Anxiety Levels in Gynecological Cancer Patients Receiving Chemotherapy.; State and trait anxiety scale; Chronic Disease Adjustment Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov